Phase III/IV (Integrated)

217 trials 105 recruiting

Filter these 217 trials by condition, country, sponsor and more.

Open in Search →

[68Ga]-FAPI PET/CT to visualize the activity of fibrogenic cells in patients with non-resolving shock lung. Recruiting

2024-517257-27-00 Non-resolving ARDS 2024-11-24
GSDIa Disease Monitoring Program Recruiting

2023-510219-20-00 Glycogen storage disease type Ia (GSDIa) 2024-11-04
Comparison of topical hydrocortisone versus dexamethasone treatment for inflammatory secretions of the conjunctiva in patients with ocular p… Recruiting

2024-517441-14-00 inflammatory secretions of the conjunctiva (Eye desease 2024-10-30
The BLESS Trial Recruiting

2024-513360-25-00 Any cancer with cutaneous malignancies 2024-10-29
The effect of acupuncture or metformin for improvement of insulin sensitivity in women with Polycystic Ovary Syndrome Recruiting

2024-514505-64-01 Polycystic ovary syndrome 2024-10-18
PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized… Recruiting

2023-504144-33-01 esophageal cancer 2024-10-17
Tranexamic acid to prevent OpeRation in Chronic subdural Hematoma (TORCH) Recruiting

2024-514927-40-02 Chronic Subdural Hematoma 2024-10-01
A lower dose olaparib, combined with a drug which inhibits olaparib degradation, to increase tolerability and decrease the price of the trea… Recruiting

2024-516414-38-00 Cancer 2024-10-01
Alpha 2 adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): randomis… Recruiting

2023-510212-39-00 Delirium 2024-09-10
FLUOCOL-1 : Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage Recruiting

2024-515118-42-00 Colorectal cancer 2024-09-10
Efficacy and safety of Cerebrolysin for neurorecovery after moderate-severe traumatic brain injury Recruiting

2024-515591-12-00 Traumatic brain injury 2024-08-27
Effectiveness and safety of combined autologous Platelet Rich Plasma and Focal Shockwave Therapy for the treatment of erectile dysfunction Recruiting

2024-517248-73-00 Erectile dysfunction 2024-08-19
IDEAL-COR Recruiting

2023-505270-15-00 Overweight and obesity 2024-08-19
CLEAR-PATH trial Recruiting

2024-513363-15-01 (Chronic) Peripheral (occlusive) arterial disease (PAD) 2024-07-22
Improvement of MRI assessed cerebral Perfusion and oxygenation by luspatercept-induced Anemia Correction in non-transfusion dependent Thalas… Recruiting

2023-504908-28-01 Non-transfusion dependent beta-thalassmia 2024-07-14
IMpact of Phenylephrine vs. norAdrenaline on systemic hemodynamics and Cerebral Tissue circulation and oxygenation in anesthetized brain tum… Recruiting

2024-515400-40-00 low blood pressure during anesthesia 2024-07-04
“Randomized controlled multicenter study comparing efficacy and safety of adalimumab to that of mycophenolate mofetil in steroid dependent n… Recruiting

2023-505112-38-00 recently active non-infectious intermediate, posterior, 2024-07-01
Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LVERU®JUNIOR and 2LVERU® on the treatment of warts. EVAsION … Recruiting

2024-514476-40-00 Non genital warts infection 2024-06-03
VulVaccin study Recruiting

2023-506792-94-00 Vulvar High-Grade Squamous Intraepithelial Lesion (vHSI 2024-03-04
IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs – a pragmatic randomized-contr… Recruiting

2023-506620-87-00 Advanced Breast Cancer in older patients 2024-01-25
STEPS-EA trial Recruiting

2023-504905-36-00 Strictures after esophageal atresia repair 2024-01-11
Randomized trial comparing efficacy and safety of initial triple therapy including parenteral treprostinil to initial double oral therapy in… Recruiting

2023-504351-26-01 Pulmonary arterial hypertension (group I) 2023-12-06
Optimal medical treatment of difficult-to-treat hypertension. Recruiting

2024-517628-20-00 hypertension 2023-10-24
The OPTIMIST study Recruiting

2023-505940-20-00 osteoporosis 2023-09-26